Technical Analysis for DXR - Daxor Corporation

Grade Last Price % Change Price Change
grade D 9.66 2.22% 0.21
DXR closed up 2.22 percent on Friday, May 17, 2019, on 21 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
0 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Down Down
See historical DXR trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
1,2,3 Retracement Bearish Bearish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Stochastic Reached Oversold Weakness 0.00%
Inside Day Range Contraction 0.00%
Oversold Stochastic Weakness 0.00%
20 DMA Resistance Bearish 2.22%
1,2,3 Retracement Bearish Bearish Swing Setup 2.22%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 2.22%
200 DMA Support Bullish 2.22%

Older signals for DXR ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Get Started for Free!
Configure default chart indicators
Basic chart:

Profile
Daxor Corporation, a medical device manufacturing company, offers biotech services in the United States. The company develops and markets BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume. BVA-100 Blood Volume Analyzer is used to diagnose and treat patients with heart failure, kidney failure, hypertension, and syncope; aid in fluid and blood transfusion management in the critical care unit; and aid in the diagnosis and treatment of disorders of red blood cell volume, including polycythemia and anemia, as well as used in pre-surgical evaluation of red blood cell volume. The company also provides cryobanking services, including blood and semen storage and related services. Daxor Corporation markets its products to hospitals and radiology imaging centers. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was founded in 1970 and is headquartered in New York, New York.
Medical Specialties Disorders Heart Failure Hypertension Blood Anemia Transfusion Medicine Hematology Science Blood Transfusion Kidney Failure Hematopathology Red Blood Cell Syncope
Is DXR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
May 6 SBGI, AMG, GIII and ZNH among notable midday movers
May 6 ImmunoGen and Athenex among healthcare gainers; AAC Holdings and PetMed Express among losers
Mar 21 Daxor Corporation Addresses and Corrects Erroneous Seeking Alpha Healthcare News Editor Article of March 20, 2019
Mar 20 Daxor down 11% after corporate presentation
Mar 15 Daxor Corporation to Present at the 31st Annual Roth Conference on March 19, 2019
Mar 4 Daxor Corporation Announces Rise in Kit Sales and Files Form N-CSR For 2018
Feb 22 Daxor's BVA-100 demonstrates ease of use in critically ill patients
Feb 22 New Research Further Demonstrates Clinical Utility and Improved Ease of Use with Daxor Corporation’s Blood Volume Analyzer (BVA-100®) in Critical Care
Feb 13 Daxor Corporation to Exhibit at the Society for Critical Care Medicine 48th Congress
Feb 1 45 Stocks Moving In Friday's Mid-Day Session
See more DXR news...
Indicators
Indicator Value
52 Week High 19.95
52 Week Low 4.3
Average Volume 26,319
200-Day Moving Average 9.3811
50-Day Moving Average 10.9803
20-Day Moving Average 9.7468
10-Day Moving Average 10.0785
Average True Range 0.7068
ADX 30.25
+DI 13.317
-DI 22.5751
Chandelier Exit (Long, 3 ATRs ) 9.1796
Chandelier Exit (Short, 3 ATRs ) 11.157199999999999
Upper Bollinger Band 10.6894
Lower Bollinger Band 8.8042
Percent B (%b) 0.45
BandWidth 19.341733
MACD Line -0.3065
MACD Signal Line -0.3979
MACD Histogram 0.0913
Fundamentals Value
Market Cap 36.62 Million
Num Shares 3.79 Million
EPS -0.21
Price-to-Earnings (P/E) Ratio -46.00
Price-to-Sales 30.32
Price-to-Book 1.11
PEG Ratio 0.00
Dividend 0.03
Dividend Yield 0.31%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 10.19
Resistance 3 (R3) 10.18 9.98 10.10
Resistance 2 (R2) 9.98 9.85 9.99 10.07
Resistance 1 (R1) 9.82 9.76 9.90 9.84 10.04
Pivot Point 9.63 9.63 9.67 9.64 9.63
Support 1 (S1) 9.47 9.49 9.55 9.48 9.28
Support 2 (S2) 9.27 9.41 9.28 9.25
Support 3 (S3) 9.11 9.27 9.22
Support 4 (S4) 9.13